Target Validation Information
TTD ID	T20710
Target Name	Interleukin 2 receptor (IL2R)
Type of Target	Successful
Drug Potency against Target	Basiliximab	Drug Info	IC50 = 0.14 nM	[1]
References
REF 1	Structural basis for the blockage of IL-2 signaling by therapeutic antibody basiliximab. J Immunol. 2010 Feb 1;184(3):1361-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.